• UCLA Health
  • myUCLAhealth
  • School of Medicine
Radiation Oncology UCLA

UCLA Radiation Oncology

Radiation Oncology UCLA
  • Explore UCLA Radiation Oncology
    • Chair's Welcome
    • Contact Us
    • In the News
    • Newsletters
    • Webinars
    • Innovation & Technology
    • Maps and Directions
    • Scholarly Activity
    • How You Can Help
    • Refer a Patient
  • For Patients
    • Appointments
    • Patient Education Video
    • First Visit for Patients
    • FAQs
    • Testimonials
    • Patient Stories
    • Radiation Oncology Treatment Team
    • Resources / Links
    • Clinical Trials
    • Contact Us
    • Maps and Directions
    • Health Plans
  • Services & Specialties
    • Clinical Programs
    • Brain & Spine Tumors
    • Breast Cancer
    • GI Cancers (Rectal, Anal, Pancreas)
    • GU Cancers (Prostate, Bladder, Kidney)
    • Gynecologic Cancers
    • Head and Neck Cancer
    • Lung Cancer
    • Lymphoma
    • Sarcoma
    • Skin Cancer
  • Brachytherapy at UCLA
    • Treatments Offered
    • Fellowship Program
    • Patient Forms and Information
    • Contact Us
  • Education
    • Medical Residency Program
    • Welcome and Overview
    • Conferences and Courses
    • Brachytherapy Fellowship Program
    • BioMedical Physics Graduate Program
    • Medical Physics Residency Program
    • Medical Student Rotation
  • Research
    • Division of Molecular and Cellular Oncology
    • Clinical Research Team
    • Medical Physics Research
    • Translational Research
  • Clinical Trials
  • Our Expert Team
    • Physicians
    • Brachytherapy Team
    • Clinical Research Team
    • Division of Molecular and Cellular Oncology Research Faculty
    • Dosimetrists
    • Medical Residents
    • Nursing and Social Worker Services
    • Physicists
    • Radiation Therapists
    • Social Workers
    • Refer a Patient
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Radiation Oncology

Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma

  1. Home
  2. Clinical Trials
  3. Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma

Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma

Share this

Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma Utilizing an MRI-Guided Tri-60 Teletherapy System

Clinical Trial:  Liver Cancer

Testing the Feasibility of a Unique Radiation Therapy Machine Which is Guided by MRI for People with Liver Cancer

Basic Information:

Standard treatment for tumors of the liver includes stereotactic body radiotherapy (SBRT). While SBRT is effective, very often an extra amount of radiation must be added to ensure the SBRT treatment is reaching the location of the tumor.

Combining MRI with radiation therapy may enable us to highlight the tissues surrounding the tumor better, which can help us see soft tissue and visualize and adjust the radiation dose, without invasive procedures or exposing patients to additional radiation, which is common with other radiation treatment types. We hope to eliminate the number of normal tissues exposed to radiation and increase tumor control through this system. 

This study does not replace any of the routine radiation treatment patients would typically receive at UCLA. Instead, the purpose of this research study is to determine if the new MRI-guided system can be used to develop optimal treatment plans for liver SBRT.

Research Procedures:

All treatment in this study is considered standard of care, and uses an FDA-approved device, the Viewray system™.

Subjects will undergo routine radiation therapy planning which includes either MRI, CT scans or a combination of both.

Standard, routine radiation will be delivered in five separate doses, requiring five separate visits to UCLA Department of Radiation Oncology.  Patients will return to UCLA for routine follow-up visits after the completion of radiation therapy, which take place about once every three months for the first year.

Eligibility Criteria (Basic):

  • Must be 18 years of age or older
  • Must have cancer present in the liver either due to metastases or due to primary liver cancer

Other eligibility criteria exist.

For More Detailed Information Contact:

  • Percy Lee, MD, Principal Investigator (310) 825-9775
  • Jackie Hernandez, Clinical Study Coordinator (310) 267-8991
  • UCLA Department of Radiation Oncology (310) 825-6577
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare
  • UCLA Health
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Publications
  • Giving
  • Careers
  • Volunteer
  • Privacy Practices
  • Nondiscrimination
  • Emergency
  • Smoke-Free
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Report Broken Links
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare